FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cord Blood Transfusion In Preterm Neonates (CB-TrIP)

Completed

Conditions: Premature Infant Disease
Transfusion Related Complication
Fetal Hemoglobin

First Posted Date: 2018-12-05

Last Posted Date: 2021-08-17

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 25

Registration Number: NCT03764813

Locations: 🇮🇹
Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy
🇮🇹
Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy

Effectiveness of a VAP Prevention Bundle in the PICU

Conditions: Ventilator Associated Pneumonia

Interventions: Other: Evaluation of VAP incidence before the protocol introduction
Other: Measures for the VAP prevention in the PICU

First Posted Date: 2018-12-04

Last Posted Date: 2018-12-04

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 242

Registration Number: NCT03763695

Locations: 🇮🇹
Fondazione Policlinico Universitario Agostino Gemelli, Roma, RM, Italy

Supplementation With Lacobacillus Reuteri ATCC PTA 4659 in Patients Affected by Acute Uncomplicated Diverticulitis

Not Applicable

Completed

Conditions: Acute Diverticulitis

Interventions: Dietary Supplement: Lactobacillus Reuteri 4659
Dietary Supplement: Placebo

First Posted Date: 2018-09-04

Last Posted Date: 2022-05-05

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 90

Registration Number: NCT03656328

Locations: 🇮🇹
Policlinico universitario agostino gemelli, Roma, Italy

Reduction of Pain Symptoms With Stereotactic Radiotherapy on Bone Metastases

Not Applicable

Conditions: Technology
Bone Metastases
Radiotherapy

Interventions: Radiation: Simultaneous Integrated Boost-SIB on macroscopic metastases

First Posted Date: 2018-07-24

Last Posted Date: 2019-07-05

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 330

Registration Number: NCT03597984

BReak Interval Delayed Surgery for Gastrointestinal Extraperitoneal Rectal Cancer

Not Applicable

Conditions: Rectal Cancer

Interventions: Diagnostic Test: Repetition of Re-staging

First Posted Date: 2018-07-10

Last Posted Date: 2022-01-11

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 148

Registration Number: NCT03581344

Locations: 🇮🇹
Fondazione policlinico universitario a. gemelli IRCCS, Rome, Italy

SEntine Lymph Node in earLY Ovarian Cancer (SELLY)

Not Applicable

Completed

Conditions: Sentinel Lymph Node
Ovarian Cancer Stage I

Interventions: Procedure: Sentinel node detection

First Posted Date: 2018-06-20

Last Posted Date: 2023-06-22

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 176

Registration Number: NCT03563781

Locations: 🇮🇹
Giovannni Scambia, Rome, Italy

Single frActIoN eighT Gray Palliative Radiotherapy With Modulated Intensity for Pain Reduction

Conditions: Bone Metastases
Radiotherapy
Technology

First Posted Date: 2018-06-12

Last Posted Date: 2018-08-29

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 50

Registration Number: NCT03554135

Effect of Crystalloids With Different SID on pH, and Urinary Electrolytes During General Anesthesia

Not Applicable

Completed

Conditions: SID
Acid-Base Imbalance

Interventions: Other: 0.9% saline administration
Other: Ringer's lactate administration
Other: Plasmalyte-like solution administration

First Posted Date: 2018-04-24

Last Posted Date: 2024-03-26

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 45

Registration Number: NCT03507062

Locations: 🇮🇹
Fondazione Policlinico A. Gemelli, Roma, Italy

Hemodynamic Optimization During Major Urological Surgery

Completed

Conditions: Hemodynamic Instability

Interventions: Device: Ev1000 Clinical Platform from Edwards Lifesciences

First Posted Date: 2018-03-22

Last Posted Date: 2022-06-07

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 30

Registration Number: NCT03474224

Locations: 🇮🇹
Andrea Russo, Rome, Italy

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Phase 1

Recruiting

Conditions: Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Interventions: Drug: Carboplatin
Drug: Paclitaxel
Drug: Bevacizumab
Drug: Rucaparib

First Posted Date: 2018-03-12

Last Posted Date: 2021-08-27

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 290

Registration Number: NCT03462212

Locations: 🇮🇹
Ospedale Mater Salutis, Legnago, Italy
🇮🇹
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy
🇮🇹
Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy